MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia — Stella

Home/Acute Lymphoblastic Leukemia/

View on ClinicalTrials.gov

Recruiting

Back to Acute Lymphoblastic Leukemia trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Jordan

King Hussein Cancer Center, Amman

Key details

Sponsor

King Hussein Cancer Center

Enrollment target

~12 participants

Started

February 2026

Primary completion

January 2029

Age range

1 Year and older

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.